Thyrolar Tablet

Introduction

Thyrolar Tablet 50 mcg is a synthetic form of the thyroid hormone thyroxine (T4). It is used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormones. Levothyroxine helps to normalize thyroid hormone levels in the body, thus maintaining proper metabolic function.

Uses

Thyrolar Tablet 50 mcg is primarily used to treat hypothyroidism. It is also used to manage thyroid-stimulating hormone (TSH) suppression in patients with thyroid cancer and to treat goiter (enlarged thyroid gland) from various causes. Additionally, it may be used as part of the treatment regimen for certain types of thyroiditis.

Brand Name	Thyrolar
Type	Tablet
Weight	50 mcg
Generic	Levothyroxine Sodium
Manufacturer	ACME Laboratories Ltd.
Available in	English বাংলা

Mechanism of Action

Thyrolar Tablet 50 mcg works by providing an exogenous source of thyroid hormone, which is normally produced by the thyroid gland. Once administered, it is converted to its active form, triiodothyronine (T3), which then regulates various metabolic processes in the body, including growth, energy production, and thermoregulation.

How Long Does It Take to Work?

The effects of Thyrolar Tablet 50 mcg can be observed within 1 to 2 weeks of starting treatment, with full therapeutic effects typically taking several weeks to months. The time frame for symptom relief can vary based on individual patient response and dosage adjustments.

Absorption

Thyrolar Tablet 50 mcg is well absorbed from the gastrointestinal tract. Peak plasma concentrations are usually reached within 2 to 4 hours after oral administration. Absorption can be affected by food, so it is generally recommended to take the medication on an empty stomach.

Route of Elimination

Thyrolar Tablet 50 mcg is primarily eliminated through the liver and kidneys. It is metabolized to T3 in peripheral tissues and excreted in the urine as inactive metabolites. A small portion is also eliminated in the feces.

Dosage

Adult dose:

Initial starting dose: 25-50 mcg/day, with gradual increments in dose at 6-8 week intervals, as needed. The Levothyroxine Sodium dose is generally adjusted in 12.5-25 mcg increments until the patient with primary hypothyroidism is clinically euthyroid and the serum TSH has normalized.
In patients with severe hypothyroidism: Initial dose is 12.5-25 mcg/day with increases of 25 mcg/day every 2-4 weeks, accompanied by clinical and laboratory assessment,until the TSH level is normalized.
In patients with secondary (pituitary) or tertiary (hypothalamic) hypothyroidism: Levothyroxine Sodium dose should be titrated until the patient is clinically euthyroid and the serum free - T4 level is restored to the upper half of the normal range.
For patients older than 50 years or for patients under 50 years of age with underlying cardiac disease: 1.7 mcg/kg/day.

Pediatric Dosage (Newborns): The recommended starting dose is 10-15 mcg/kg/day. A lower starting dose should be considered in infants at risk for cardiac failure and the dose should be increased in 4-6 weeks as needed based on clinical and laboratory response to treatment. In infants with very low (<5 mcg/dL) or undetectable serum T4 concentrations, the recommended initial starting dose is 50 mcg/day of Levothyroxine Sodium.

Pediatric Dosage (Infants and Children): In children with chronic or severe hypothyroidism, initial dose of 25 mcg/day with increments of 25 mcg every 2-4 weeks until the desired effect is achieved. Hyperactivity in an older child can be minimized if the starting dose is one-fourth of the recommended full replacement dose and the dose is then increased on a weekly basis by an amount equal to one-fourth the full recommended replacement dose until the full recommended replacement dose is reached.

0-3 months: 10-15 mcg/kg/day
3-6 months: 8-10 mcg/kg/day
6-12 months: 6-8 mcg/kg/day
1-5 years: 5-6 mcg/kg/day
6-12 years: 4-5 mcg/kg/day
>12 years but growth and puberty incomplete: 2-3 mcg/kg/day
Growth and puberty complete: 1.7 mcg/kg/day.

The dose should be adjusted based on clinical response and laboratory parameters.

The dosage of Thyrolar Tablet 50 mcg varies depending on the individual's age, weight, and clinical condition. The typical starting dose for adults with hypothyroidism is 50 to 100 mcg daily, with adjustments made based on thyroid function tests. For children and elderly patients, dosing is adjusted accordingly. In cases of thyroid cancer or other conditions requiring TSH suppression, higher doses may be prescribed.

Administration

Thyrolar Tablet 50 mcg is administered orally in tablet form. It should be taken at the same time each day, preferably on an empty stomach, 30 to 60 minutes before breakfast. Consistency in timing and method of administration helps maintain stable thyroid hormone levels.

Side Effects

Common side effects include palpitations, weight loss, increased appetite, sweating, and nervousness. Some patients may also experience insomnia or gastrointestinal disturbances. Most side effects are related to dosage adjustments and typically resolve once the correct dosage is achieved.

Toxicity

Toxicity from Thyrolar Tablet 50 mcg can result in symptoms such as tachycardia (rapid heart rate), chest pain, tremors, and weight loss. Severe toxicity can lead to hyperthyroidism symptoms, including severe arrhythmias and osteoporosis. Treatment involves adjusting the dose and managing symptoms.

Precautions

Precautions should be taken in patients with cardiovascular disease, diabetes, or adrenal insufficiency. Regular monitoring of thyroid function tests is required to adjust dosage and prevent potential complications. Thyrolar Tablet 50 mcg should be used cautiously in the elderly and in patients with significant comorbidities.

Interaction

Thyrolar Tablet 50 mcg may interact with medications such as anticoagulants, antidepressants, and certain antiepileptics. It can also interact with calcium and iron supplements, which can reduce its absorption. Regular monitoring and dosage adjustments may be necessary when used with other drugs.

Disease Interaction

Thyrolar Tablet 50 mcg should be used with caution in patients with pre-existing cardiovascular conditions, diabetes, and adrenal insufficiency. It is important to monitor these conditions closely and adjust treatment as needed.

Drug Interaction

Drug interactions with Thyrolar Tablet 50 mcg can affect its efficacy and metabolism. For example, drugs like antacids, proton pump inhibitors, and some cholesterol-lowering agents can interfere with its absorption. Coordination with healthcare providers is essential to manage these interactions effectively.

Food Interactions

Food, especially high-fiber foods, can affect the absorption of Thyrolar Tablet 50 mcg. It is generally recommended to take the medication on an empty stomach and avoid consuming high-fiber foods or supplements around the time of administration.

Pregnancy Use

Thyrolar Tablet 50 mcg is classified as Category A for pregnancy, indicating that it is considered safe to use during pregnancy. Proper thyroid hormone levels are crucial for the health of both the mother and the developing fetus. Dosage adjustments may be necessary as pregnancy progresses.

Lactation Use

Thyrolar Tablet 50 mcg is excreted in breast milk in very small amounts. It is considered safe for use during breastfeeding, and no special precautions are typically required. Regular monitoring of thyroid function in the mother and infant may be necessary.

Acute Overdose

Acute overdose of Thyrolar Tablet 50 mcg can lead to symptoms of hyperthyroidism such as rapid heartbeat, tremors, and nervousness. Treatment involves managing symptoms, discontinuing the medication, and potentially administering activated charcoal if the overdose is recent.

Contraindication

Thyrolar Tablet 50 mcg is contraindicated in patients with untreated thyrotoxicosis (overactive thyroid) and acute myocardial infarction. It should be avoided in individuals with hypersensitivity to the drug or any of its components.

Use Direction

Thyrolar Tablet 50 mcg should be taken exactly as prescribed. Consistency in timing and administration is crucial for maintaining effective thyroid hormone levels. Regular follow-up with a healthcare provider is necessary to monitor thyroid function and adjust the dosage as needed.

Storage Conditions

Thyrolar Tablet 50 mcg should be stored at room temperature, away from moisture and heat. Keep the medication in its original container to protect it from light and humidity. Do not use the medication past its expiration date.

Volume of Distribution

The volume of distribution of Thyrolar Tablet 50 mcg is approximately 10 to 15 liters, indicating that it is distributed throughout the body’s tissues and fluids.

Half Life

The elimination half-life of Thyrolar Tablet 50 mcg is approximately 6 to 7 days, which allows for once-daily dosing and helps maintain stable hormone levels with consistent use.

Clearance

Thyrolar Tablet 50 mcg is primarily cleared through the liver and kidneys. Its clearance rate can be affected by liver function and renal impairment, requiring dose adjustments in patients with compromised liver or kidney function.

See in details version Thyrolar Tablet 50 mcg also Thyrolar Tablet 50 mcg in bangla